Pharmaceuticals News and Research

RSS

Podcast: KHN’s ‘What the Health?’ Ask us anything!

This week, KHN's "What the Health?" panelists answered questions submitted by listeners.

31 Aug 2018

Eagle Pharmaceuticals completes enrollment of second clinical study to evaluate safety, efficacy of RYANODEX

Eagle Pharmaceuticals, Inc. today announced completion of enrollment of the Company's second clinical study to further evaluate the safety and efficacy of RYANODEX® (dantrolene sodium for injectable suspension) for the treatment of exertional heat stroke, an investigational new indication for the product.

30 Aug 2018

Celmatix and Ferring announce genomics collaboration aimed at uncovering new insights into ovarian biology

Ferring Pharmaceuticals and Celmatix today announced an ambitious genomics collaboration aimed at uncovering new insights into ovarian biology and accelerating the development of personalized interventions in reproductive medicine and women's health.

30 Aug 2018

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

Alnylam Pharmaceuticals, Inc., the leading RNAi therapeutics company, announced today that the European Commission (EC) has granted marketing authorization for ONPATTRO (patisiran) for the treatment of hereditary transthyretin-mediated (hATTR) amyloidosis in adults with stage 1 or stage 2 polyneuropathy.

30 Aug 2018

Vertex, Genomics team up to improve discovery of precision medicines

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Genomics plc today announced a three-year collaboration, extendable to five years, to use human genetics and machine learning to improve discovery of targets for precision medicines, and to advance understanding of the clinical impact of human genetic variation and patient stratification in diseases with significant unmet need.

30 Aug 2018

Component of cannabis could help in psychosis

Researchers from King’s College London have now found how the chemical cannabidiol or CBD from cannabis can reduce the abnormal brain activity in patients who are at risk of psychosis. The study was published in the latest issue of the journal JAMA Psychiatry.

30 Aug 2018

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Johns Hopkins Medicine researchers say new experiments using magnetic pulse brain stimulation on people with moderate to severe restless legs syndrome have added to evidence that the condition is due to excitability and hyperarousal in the part of the brain's motor cortex responsible for leg movement.

29 Aug 2018

Developing a Flexible X-ray Detector

In this interview, Dr. Imalka Jayawardena from the University of Surrey talks about the development of a flexible X-ray detector that will help clinicians analyze X-ray images and deliver targeted doses of radiation when using X-rays as a treatment.

29 Aug 2018

$Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction$

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Data from the TRANSITION study presented today at the European Society of Cardiology Congress in Munich, Germany has shown that Entresto® can be initiated early and safely in a wide range of heart failure patients with reduced ejection fraction who have been stabilized after hospitalization due to an acute heart failure episode.

25 Aug 2018

Podcast: KHN’s ‘What the Health?’ Opioids, epipens and health funding

The Senate is still working, well into August - something it hasn't done in years — and it’s debating the funding bill for the Department of Health and Human Services.

24 Aug 2018

KNAUER introduces single quadrupole mass spectrometer

KNAUER launched a single quadrupole mass spectrometer. With the KNAUER 4000MiD the Berlin-based company expands their preparative HPLC portfolio to the field of mass directed purification.

From KNAUER Wissenschaftliche Geräte GmbH 23 Aug 2018

PETA reports show that animal research failed to benefit human health

Animal research has failed to benefit human health, wasted limited public research funds, misled clinicians, and harmed countless animals unnecessarily, finds a new report by PETA scientists Emily Trunnell, Ph.D., and Frances Cheng, Ph.D.

23 Aug 2018

Postnova Analytics reports on characterization of self-assembling block copolymers

Postnova Analytics reports on how Thermal Field Flow Fractionation has been successfully used to elucidate the core microstructure, morphology and chain arrangement of self-assembling block copolymers. This pioneering study was undertaken by the renowned research group under Professor H Pasch at the Department of Chemistry and Polymer Science, University of Stellenbosch (South Africa).

From Postnova Analytics 22 Aug 2018

New proposal aims to improve drug harm assessment process

A drug policy researcher is proposing a suite of changes to overhaul the Multi-Criteria Drug Harm Scale, which informs drug policies across Europe.

20 Aug 2018

The man who sold America on vitamin D — and profited in the process

Dr. Michael Holick's enthusiasm for vitamin D can be fairly described as extreme.

20 Aug 2018

URI professor develops simpler and quicker method for detecting impurity in heparin

In 2008, a contaminant eluded the quality safeguards in the pharmaceutical industry and infiltrated a large portion of the supply of the popular blood thinner heparin, sickening hundreds and killing about 100 in the U.S.

19 Aug 2018

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Xeris Pharmaceuticals, Inc., a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that Jessica Castle, M.D., an associate professor of medicine in the OHSU School of Medicine and OHSU Harold Schnitzer Diabetes Health Center in Portland, Oregon, is conducting a clinical trial with a dual-hormone artificial pancreas using Xeris' ready-to-use liquid glucagon to evaluate a new closed-loop algorithm.

17 Aug 2018

Podcast: KHN’s ‘What the Health?’ See you in court!

A federal district court judge in Texas has set Sept. 10 as the date for oral arguments in a case filed by Republican state attorneys general and governors from 20 states.

17 Aug 2018

FDA grants approval for first generic version of epinephrine auto-injector

The U.S. Food and Drug Administration today approved the first generic version of EpiPen and EpiPen Jr (epinephrine) auto-injector for the emergency treatment of allergic reactions, including those that are life-threatening (anaphylaxis), in adults and pediatric patients who weigh more than 33 pounds.

16 Aug 2018

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Vertex Pharmaceuticals Incorporated today announced the U.S. Food and Drug Administration approved KALYDECO® (ivacaftor) to include use in children with cystic fibrosis ages 12 to <24 months who have at least one mutation in their cystic fibrosis transmembrane conductance regulator gene that is responsive to KALYDECO based on clinical and/or in vitro assay data.

16 Aug 2018

Pharmaceuticals News and Research

Podcast: KHN’s ‘What the Health?’ Ask us anything!

Eagle Pharmaceuticals completes enrollment of second clinical study to evaluate safety, efficacy of RYANODEX

Celmatix and Ferring announce genomics collaboration aimed at uncovering new insights into ovarian biology

EC grants marketing authorization for ONPATTRO (patisiran) in Europe

Vertex, Genomics team up to improve discovery of precision medicines

Component of cannabis could help in psychosis

New study supports motor cortex 'excitability' as cause of restless legs syndrome

Developing a Flexible X-ray Detector

Entresto drug can be initiated early and safely in heart failure patients with reduced ejection fraction

Podcast: KHN’s ‘What the Health?’ Opioids, epipens and health funding

KNAUER introduces single quadrupole mass spectrometer

PETA reports show that animal research failed to benefit human health

Postnova Analytics reports on characterization of self-assembling block copolymers

New proposal aims to improve drug harm assessment process

The man who sold America on vitamin D — and profited in the process

URI professor develops simpler and quicker method for detecting impurity in heparin

OHSU professor conducts clinical trial with artificial pancreas using Xeris' liquid glucagon

Podcast: KHN’s ‘What the Health?’ See you in court!

FDA grants approval for first generic version of epinephrine auto-injector

FDA expands approval of Vertex' cystic fibrosis medicine to treat children aged 12 to <24 months

Ultimate guide to the essential tools for the characterization of proteins, polymers and nanoparticles eBook

Latest eBooks

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring